Iguchi, H., Suzuki, N., Uesugi, K., Tanaka, H., Hirakawa, K., Aruga, A., Hatori, T., Ishizaki, H., Umeda, Y., Fujiwara, T., Shimada, M., Ikemoto, T., Yoshimatsu, K., Shimizu, R., Hayashi, H., Sakata, K., Yoshino, S., Furukawa, H., Hazama, S., & Oka, M. (n.d.). 530 A phase II study of cancer vaccination using three peptides combination with gemcitabine as a first-line therapy for advanced pancreatic cancer (VENUS-PC study). European journal of cancer, 51, S114–. http://access.bl.uk/ark:/81055/vdc_100030628048.0x00001a